Leucidal® SF Max is a high-specification antimicrobial produced through the fermentation of Lactobacillus in a defined medium. It is an “optimized iteration” featuring a tightened concentration of bacteriocins—the antimicrobial peptides that drive its efficacy. The manufacturing process uses papaya-derived lysozyme to facilitate controlled cell lysis, ensuring the maximum release of these bioactive peptides for superior performance.
Key Features & Technical Benefits
-
Broad-Spectrum Efficacy: Demonstrates notably low and uniform Minimum Inhibitory Concentrations (MIC) against all five standard challenge test organisms.
-
Clinically Proven Barrier Support:
-
Hydration: Measurable improvement in hydration % after 24 hours and 4 weeks.
-
Barrier Function: Significant reduction in Transepidermal Water Loss (TEWL) after 3 weeks.
-
Skin Density: High-resolution ultrasound imaging confirmed improved skin density versus untreated skin.
-
-
Salicylate-Free Regulation: this Leucidal® version does not contain natural salicylates. It is exempt from EU Annex III and Annex V restrictions, making it the preferred choice for baby care (under 3 years), oral care, and spray applications.
Formulation & Handling
-
Stability: register to find out
-
Incorporation: Must be added during the cooling phase. For optimal results, add before viscosity modifiers to ensure proper dispersion.
